Prime Medicine, Inc. (PRME)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 800K 1.6M 2.4M Q1 '24: 591K Q2 '24: 0 Q3 '24: 209K Q4 '24: 2.2M Q1 '25: 1.5M Q2 '25: 1.1M Q3 '25: 1.2M Q4 '25: 838K Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -54.2M Q4 '24: -44.2M Q1 '25: -52.4M Q2 '25: -53.4M Q3 '25: -54M Q4 '25: -48.6M Q1 '26: -50.7M Q2 '26: -43.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -52.5M Q4 '24: -42.3M Q1 '25: -51.9M Q2 '25: -52.6M Q3 '25: -50.6M Q4 '25: -46.1M Q1 '26: -49.1M Q2 '26: -42.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -25.9M Q4 '24: 16.2M Q1 '25: -48.9M Q2 '25: -41.4M Q3 '25: -35M Q4 '25: -37.3M Q1 '26: -42.7M Q2 '26: -41M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -27.2M Q4 '24: 14.5M Q1 '25: -51.3M Q2 '25: -43M Q3 '25: -35.3M Q4 '25: -37.5M Q1 '26: -42.9M Q2 '26: -41.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '24: 104.5M Q2 '24: 119.2M Q3 '24: 119.8M Q1 '25: 130.9M Q2 '25: 129.2M Q3 '25: 160.5M Q1 '26: 177.1M Q2 '26: 177.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q3 '24: -2.06 Q4 '24: -1.65 Q1 '25: -1.61 Q2 '25: -1.56 Q3 '25: -1.44 Q4 '25: -1.37 Q1 '26: -1.25 Q2 '26: -1.08 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.